Differential effects of PPARγ activation by the oral antidiabetic agent pioglitazone in Barrett's carcinoma in vitro and in vivo

Medizinische Klinik Und Poliklinik Ii University Of Wuerzburg

Medizinische Klinik Und Poliklinik Ii University Of Wuerzburg

Medizinische Klinik II, Klinikum Aschaffenburg

Department of Surgery, University of Wuerzburg

Department of Pathology, University of Wuerzburg

Department for Internal Medicine, Kreiskrankenhaus Nagold

Central Institute for Clinical Chemistry and Laboratory Diagnostics, University of Duesseldorf

Medizinische Klinik und Poliklinik II, University of Wuerzburg

Division of Endocrinology and Diabetology, Department of Internal Medicine II, University Hospital o

Department For Internal Medicine Kreiskrankenhaus Nagold

Medizinische Klinik Ii Klinikum Aschaffenburg

Department Of Surgery University Of Wuerzburg

Department Of Surgery University Hospital University Of Wurzburg Germany

Division Of Endocrinology And Diabetology Department Of Internal Medicine Ii University Hospital Of

Medizinische Klinik Und Poliklinik Ii University Of Wuerzburg

Department Of Pathology University Of Wuerzburg

Central Institute For Clinical Chemistry And Laboratory Diagnostics University Of Duesseldorf